Filing Details

Accession Number:
0001299130-23-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-06 16:46:54
Reporting Period:
2023-03-02
Accepted Time:
2023-03-06 16:46:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1299130 Pacific Biosciences Of California Inc. PACB Laboratory Analytical Instruments (3826) 161590339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1825421 G. Susan Kim Pacific Biosciences Of California, Inc.
1305 O'Brien Drive
Menlo Park CA 94025
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-02 164,200 $0.00 328,550 No 4 A Direct
Common Stock Disposition 2023-03-03 5,045 $9.49 323,505 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date.
  2. Includes 1,769 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan.
  3. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  4. This sale price represents the weighted average sale price of the shares sold ranging from $9.24 to $9.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.